112 results on '"Yanagita, Motoko"'
Search Results
52. Risk factors for venous thromboembolism in patients with nephrotic syndrome: a retrospective cohort study.
- Author
-
Shinkawa, Kanna, Yoshida, Satomi, Seki, Tomotsugu, Yanagita, Motoko, and Kawakami, Koji
- Subjects
- *
NEPHROTIC syndrome , *THROMBOEMBOLISM , *LUPUS nephritis , *ACUTE kidney failure , *VENOUS thrombosis , *COHORT analysis - Abstract
Background Nephrotic syndrome is associated with an increased risk of venous thromboembolism (VTE). However, the risk factors of VTE in nephrotic syndrome, other than hypoalbuminemia and severe proteinuria, are not well established. Therefore we aimed to investigate the risk factors of VTE in patients with nephrotic syndrome. Methods This retrospective cohort study used data from a Japanese nationwide claims database. We identified patients ≥18 years of age hospitalized with nephrotic syndrome. Through multivariable logistic regression, we determined the risk factors of VTE in patients with nephrotic syndrome during hospitalization. Results Of the 7473 hospitalized patients with nephrotic syndrome without VTE, 221 (3.0%) developed VTE. In the VTE group, 14 (6.3%), 11 (5.0%) and 198 (89.6%) patients developed pulmonary embolism, renal vein thrombosis and deep vein thrombosis, respectively. We found that female sex {odds ratio [OR] 1.39 [95% confidence interval (CI) 1.05–1.85]}, body mass index (BMI) ≥30 [OR 2.01 (95% CI 1.35–2.99)], acute kidney injury [AKI; OR 1.67 (95% CI 1.07–2.62)], sepsis [OR 2.85 (95% CI 1.37–5.93)], lupus nephritis [OR 3.64 (95% CI 1.58–8.37)] and intravenous corticosteroids use [OR 2.40 (95% CI 1.52–3.80)] were associated with a significantly higher risk of developing VTE. Conclusions In patients with nephrotic syndrome, female sex, BMI ≥30, AKI, sepsis, lupus nephritis and intravenous corticosteroid use may help evaluate the risk of VTE. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
53. Eicosapentaenoic acid attenuates renal lipotoxicity by restoring autophagic flux.
- Author
-
Yamamoto, Takeshi, Takabatake, Yoshitsugu, Minami, Satoshi, Sakai, Shinsuke, Fujimura, Ryuta, Takahashi, Atsushi, Namba-Hamano, Tomoko, Matsuda, Jun, Kimura, Tomonori, Matsui, Isao, Kaimori, Jun-Ya, Takeda, Hiroaki, Takahashi, Masatomo, Izumi, Yoshihiro, Bamba, Takeshi, Matsusaka, Taiji, Niimura, Fumio, Yanagita, Motoko, and Isaka, Yoshitaka
- Published
- 2021
- Full Text
- View/download PDF
54. Evaluation of the Quality of Life and Health-Related Quality of Life of Patients With End-Stage Kidney Disease Resulting From Kidney Transplantation Using the Kidney Disease Quality of Life-Short Form and EuroQOL-5 Dimension-5 Level Questionnaires.
- Author
-
Sawada, Atsuro, Hiragi, Shusuke, Tamura, Hiroshi, Goto, Rei, Matsuyama, Yoko, Sakai, Kaoru, Miyata, Hitomi, Yanagita, Motoko, Kuroda, Tomohiro, Ogawa, Osamu, and Kobayashi, Takashi
- Subjects
- *
CHRONIC kidney failure , *QUALITY of life , *KIDNEY transplantation , *KIDNEY failure , *PEARSON correlation (Statistics) - Abstract
Renal transplantation improves the quality of life (QOL) of end-stage renal disease (ESRD) patients with renal failure. However, it remains unclear which renal disease-specific QOL aspects determine general health-related QOL of ESRD patients. This study aimed to identify these QOL items by examining the QOL of ESRD patients using the Kidney Disease Quality of Life-Short Form (KDQOL-SF), version 1.3, and EuroQoL-5 dimension-5 levels (EQ-5D-5L) questionnaires. We conducted QOL surveys with 67 renal transplant recipients at our hospital. EQ-5D-5L, which evaluates general health-related QOL, was the response variable, and KDQOL-SF, which includes the renal disease-specific instrument and general health-related QOL SF-36 instrument, was the explanatory variable. We analyzed the effects of each KDQOL-SF domain on EQ-5D-5L using Pearson correlation coefficient. Regarding the general health-related QOL assessed by SF-36, physical health aspects, such as physical functioning (R = 0.749) and daily functioning physical (R = 0.603), showed a strong correlation with EQ-5D-5L, and the domains related to the psychological and social aspects of QOL showed a limited correlation. Regarding kidney disease-specific scales, symptoms/problems related to physical function showed a good correlation (R = 0.691) with EQ-5D-5L, whereas other scales, including burden of kidney disease (R = 0.168), quality of social interaction (R = 0.284), and those related to the mental and social aspects of QOL showed a low correlation with EQ-5D-5L. Among kidney transplant recipients, the physical health aspects of QOL, such as symptoms/problems, were the major factors influencing overall QOL as assessed by EQ-5D-5L. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
55. Validation of the diagnostic criteria for IgG4-related kidney disease (IgG4-RKD) 2011, and proposal of a new 2020 version.
- Author
-
Saeki, Takako, Kawano, Mitsuhiro, Nagasawa, Tasuku, Ubara, Yoshifumi, Taniguchi, Yoshinori, Yanagita, Motoko, Nishi, Shinichi, Nagata, Michio, Hisano, Satoshi, Yamaguchi, Yutaka, Nomura, Hideki, Saito, Takao, and Nakashima, Hitoshi
- Subjects
- *
KIDNEY diseases , *JAPANESE people , *RENAL biopsy , *DIAGNOSTIC imaging , *PANCREATITIS , *SIALOLITHIASIS , *RETROPERITONEAL fibrosis - Abstract
Background: In 2011, the IgG4-related kidney disease (IgG4-RKD) working group of the Japanese Society of Nephrology proposed diagnostic criteria for IgG4-RKD. The aim of the present study was to validate those criteria and develop a revised version. Methods: Between April 2012 and May 2019, we retrospectively collected Japanese patients with kidney disease, for whom data on serum IgG4 values and/or immunohistological staining for IgG4 in renal biopsy samples were available. These patients were classified as IgG4-RKD or non-IgG4-RKD based on the diagnostic criteria for IgG4-RKD 2011, and the results were evaluated by expert opinion. Accordingly, we developed some revised versions of the criteria, and the version showing the best performance in the present cohort was proposed as the IgG4-RKD criteria for 2020. Results: Of 105 included patients, the expert panel diagnosed 55 as having true IgG4-RKD and 50 as mimickers. The diagnostic criteria for IgG4-RKD 2011 had a sensitivity of 72.7% and a specificity of 90.0% in this cohort. Of the 15 patients with true IgG4-RKD who were classified as non-IgG4-RKD, all lacked biopsy-proven extra-renal lesions, although many had clinical findings highly suggestive of IgG4-RD. The revised version to which "bilateral lacrimal, submandibular or parotid swelling, imaging findings compatible with type 1 autoimmune pancreatitis or retroperitoneal fibrosis" was added as an item pertaining to extra-renal organ(s) improved the sensitivity to 90.9% while the specificity remained at 90.0%. Conclusion: The revised version has considerably improved test performance after addition of the new extra-renal organ item (imaging and clinical findings). [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
56. The relationship between cigarette smoking and the tongue microbiome in an East Asian population.
- Author
-
Sato, Noriaki, Kakuta, Masanori, Uchino, Eiichiro, Hasegawa, Takanori, Kojima, Ryosuke, Kobayashi, Wataru, Sawada, Kaori, Tamura, Yoshihiro, Tokuda, Itoyo, Imoto, Seiya, Nakaji, Shigeyuki, Murashita, Koichi, Yanagita, Motoko, and Okuno, Yasushi
- Subjects
- *
EAST Asians , *SMOKING , *KREBS cycle , *EX-smokers , *DENITRIFICATION - Abstract
Background: The oral microbiome, which consists of various habitats, has been shown to be influenced by smoking. However, differences in the tongue microbiomes of current and former smokers, as well as their resultant functional consequences, have rarely been investigated in East Asian populations. Methods: We used 16S rRNA amplicon sequencing of tongue-coating samples obtained from East Asian subjects who were current, former, or never smokers to identify differences in their tongue microbiomes and related metagenomic functions. Two sets of participants from 2016 to 2017 (n = 657 and n = 187, respectively) were analyzed separately. Results: We found significant differences between the overall microbiome compositions of current versus never smokers (p = 0.0015), but not between former versus never smokers (p = 0.43) based on the weighted UniFrac distance. Twenty-nine of 43 investigated genera showed significantly different expression levels in current versus never smokers. Neisseria and Capnocytophaga were less abundant, and Streptococcus and Megasphaera were more abundant in current smokers. Moreover, the abundances of metagenomic pathways, including those related to nitrate reduction and the tricarboxylic acid cycle, were significantly different between current and never smokers. Conclusions: The tongue microbiomes and related metagenomic pathways of current smokers differ from those of never smokers among East Asians. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
57. Successful management of hyperammonemia with hemodialysis on day 2 during 5-fluorouracil treatment in a patient with gastric cancer: a case report with 5-fluorouracil metabolite analyses.
- Author
-
Ozaki, Yoshinao, Imamaki, Hirotaka, Ikeda, Aki, Oura, Mitsuaki, Nakagawa, Shunsaku, Funakoshi, Taro, Kataoka, Shigeki, Nishikawa, Yoshitaka, Horimatsu, Takahiro, Yonezawa, Atsushi, Matsubara, Takeshi, Yanagita, Motoko, Muto, Manabu, and Watanabe, Norihiko
- Subjects
- *
STOMACH cancer , *LIQUID chromatography-mass spectrometry , *CHRONIC kidney failure , *IRINOTECAN , *CANCER patients , *FLUOROURACIL , *ALANINE - Abstract
Purpose: Hyperammonemia is an important adverse event associated with 5-fluorouracil (5FU) from 5FU metabolite accumulation. We present a case of an advanced gastric cancer patient with chronic renal failure, who was treated with 5FU/leucovorin (LV) infusion chemotherapy (2-h infusion of LV and 5FU bolus followed by 46-h 5FU continuous infusion on day 1; repeated every 2 weeks) and developed hyperammonemia, with the aim of exploring an appropriate hemodialysis (HD) schedule to resolve its symptoms. Methods: The blood concentrations of 5FU and its metabolites, α-fluoro-β-alanine (FBAL), and monofluoroacetate (FA) of a patient who had hyperammonemia from seven courses of palliative 5FU/LV therapy for gastric cancer were measured by liquid chromatography–mass spectrometry. Results: On the third day of the first cycle, the patient presented with symptomatic hyperammonemia relieved by emergency HD. Thereafter, the 5FU dose was reduced; however, in cycles 2–4, the patient developed symptomatic hyperammonemia and underwent HD on day 3 for hyperammonemia management. In cycles 5–7, the timing of scheduled HD administration was changed from day 3 to day 2, preventing symptomatic hyperammonemia. The maximum ammonia and 5FU metabolite levels were significantly lower in cycles 5–7 than in cycles 2–4 (NH3 75 ± 38 vs 303 ± 119 μg/dL, FBAL 13.7 ± 2.5 vs 19.7 ± 2.0 μg/mL, FA 204.0 ± 91.6 vs 395.9 ± 12.6 ng/mL, mean ± standard deviation, all p < 0.05). After seven cycles, partial response was confirmed. Conclusion: HD on day 2 instead of 3 may prevent hyperammonemia in 5FU/LV therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
58. Prevalences of hyperuricemia and electrolyte abnormalities in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB).
- Author
-
Sofue, Tadashi, Nakagawa, Naoki, Kanda, Eiichiro, Nagasu, Hajime, Matsushita, Kunihiro, Nangaku, Masaomi, Maruyama, Shoichi, Wada, Takashi, Terada, Yoshio, Yamagata, Kunihiro, Narita, Ichiei, Yanagita, Motoko, Sugiyama, Hitoshi, Shigematsu, Takashi, Ito, Takafumi, Tamura, Kouichi, Isaka, Yoshitaka, Okada, Hirokazu, Tsuruya, Kazuhiko, and Yokoyama, Hitoshi
- Subjects
- *
CHRONIC kidney failure , *CHRONICALLY ill , *ODDS ratio , *LOGISTIC regression analysis , *ELECTRONIC health records , *COHORT analysis - Abstract
Background: The Japan Chronic Kidney Disease Database (J-CKD-DB) is a nationwide clinical database of patients with chronic kidney disease (CKD) based on electronic health records. The objective of this study was to assess the prevalences of hyperuricemia and electrolyte abnormalities in Japanese patients with CKD. Methods: In total, 35,508 adult outpatients with estimated glomerular filtration rates of 5–60 ml/min/1.73 m2 in seven university hospitals were included this analysis. The proportions of patients with CKD stages G3b, G4, and G5 were 23.5%, 7.6%, and 3.1%, respectively. Results: Logistic regression analysis showed that prevalence of hyperuricemia was associated with CKD stages G3b (adjusted odds ratio [95% confidence interval]: 2.12 [1.90–2.37]), G4 (4.57 [3.92–5.32]), and G5 (2.25 [1.80–2.80]). The respective prevalences of hyponatremia, hypercalcemia, hyperphosphatemia, and narrower difference between serum sodium and chloride concentrations were elevated in patients with CKD stages G3b, G4, and G5, compared with those prevalences in patients with CKD stage G3a. The prevalences of hyperkalemia were 8.3% and 11.6% in patients with CKD stages G4 and G5, respectively. In patients with CKD stage G5, the proportions of patients with optimal ranges of serum uric acid, potassium, corrected calcium, and phosphate were 49.6%, 73.5%, 81.9%, and 56.1%, respectively. Conclusions: We determined the prevalences of hyperuricemia and electrolyte abnormalities in Japanese patients with CKD using data from a nationwide cohort study. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
59. Metabolic effects of RUBCN/Rubicon deficiency in kidney proximal tubular epithelial cells.
- Author
-
Matsuda, Jun, Takahashi, Atsushi, Takabatake, Yoshitsugu, Sakai, Shinsuke, Minami, Satoshi, Yamamoto, Takeshi, Fujimura, Ryuta, Namba-Hamano, Tomoko, Yonishi, Hiroaki, Nakamura, Jun, Kimura, Tomonori, Kaimori, Jun-Ya, Matsui, Isao, Takahashi, Masatomo, Nakao, Motonao, Izumi, Yoshihiro, Bamba, Takeshi, Matsusaka, Taiji, Niimura, Fumio, and Yanagita, Motoko
- Published
- 2020
- Full Text
- View/download PDF
60. Developing and validating a multivariable prediction model for in-hospital mortality of pneumonia with advanced chronic kidney disease patients: a retrospective analysis using a nationwide database in Japan.
- Author
-
Takada, Daisuke, Kunisawa, Susumu, Matsubara, Takeshi, Fushimi, Kiyohide, Yanagita, Motoko, and Imanaka, Yuichi
- Subjects
- *
PNEUMONIA-related mortality , *HOSPITAL mortality , *CHRONIC kidney failure , *CHRONICALLY ill , *PREDICTION models - Abstract
Background: The prognosis of pneumonia in patients with advanced stage chronic kidney disease (CKD) remains unimproved for years. We attempt to develop a simple and more useful scoring system for predicting in-hospital mortality for advanced CKD patients with pneumonia. Methods: Using the Diagnosis Procedure Combination database, we identified the in-hospital adult patients both with a record of pneumonia and stage 5 or 5D CKD as a comorbidity on admission between April 1, 2012 and March 31, 2016. Predictive variable selection was analyzed by multivariable logistic regression analysis, stepwise method, LASSO method and random forest method, and then develop a new simple scoring system seeking for highest c-statistics combination of variables in one sample data set for model development. Finally, we compared c-statistics of univariate logistic regression about new scoring system with c-statistics about "A-DROP" in the other sample data set. Result: We identified 8402 patients in 707 hospitals, and the total in-hospital mortality was 11.0% (437 patients) in development data set. Seven variables were selected, which includes age (male ≥ 70 years, female ≥ 75 years), respiratory failure, orientation disturbance, low blood pressure, the need of assistance in feeding or bowel control, severe or moderate thinness and CRP 200 mg/L or extent of consolidation on chest X-ray ≥ 2/3 of one lung. The c-statistics of univariate logistic regression was 0.8017 using seven variables, while that was 0.7372 using "A-DROP" Conclusion: In advanced CKD patients, if we select appropriate variables for predicting in-hospital mortality, simple scoring system may have better discrimination than "A-DROP". [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
61. Prevalence of anemia in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB).
- Author
-
Sofue, Tadashi, Nakagawa, Naoki, Kanda, Eiichiro, Nagasu, Hajime, Matsushita, Kunihiro, Nangaku, Masaomi, Maruyama, Shoichi, Wada, Takashi, Terada, Yoshio, Yamagata, Kunihiro, Narita, Ichiei, Yanagita, Motoko, Sugiyama, Hitoshi, Shigematsu, Takashi, Ito, Takafumi, Tamura, Kouichi, Isaka, Yoshitaka, Okada, Hirokazu, Tsuruya, Kazuhiko, and Yokoyama, Hitoshi
- Subjects
- *
MEDICAL databases , *CHRONIC kidney failure , *CHRONICALLY ill , *ELECTRONIC health records , *COHORT analysis , *ANEMIA - Abstract
Background: The Japan Chronic Kidney Disease Database (J-CKD-DB) is a nationwide clinical database of patients with chronic kidney disease (CKD) based on electronic health records. The objective of this study was to assess the prevalence of anemia and the utilization rate of erythropoiesis-stimulating agents (ESAs) in Japanese patients with CKD. Methods: In total, 31,082 adult outpatients with estimated glomerular filtration rates of 5–60 ml/min/1.73 m2 in seven university hospitals were included this analysis. The proportions of patients with CKD stages G3b, G4, and G5 were 23.5%, 7.6%, and 3.1%, respectively. Results: The mean (standard deviation) hemoglobin level of male patients was 13.6 (1.9) g/dl, which was significantly higher than the mean hemoglobin level of female patients (12.4 (1.6) g/dl). The mean (standard deviation) hemoglobin levels were 11.4 (2.1) g/dl in patients with CKD stage G4 and 11.2 (1.8) g/dl in patients with CKD stage G5. The prevalences of anemia were 40.1% in patients with CKD stage G4 and 60.3% in patients with CKD stage G5. Logistic regression analysis showed that diagnoses of CKD stage G3b (adjusted odds ratio [95% confidence interval]: 2.32 [2.09–2.58]), G4 (5.50 [4.80–6.31]), and G5 (9.75 [8.13–11.7]) were associated with increased prevalence of anemia. The utilization rates of ESAs were 7.9% in patients with CKD stage G4 and 22.4% in patients with CKD stage G5. Conclusions: We determined the prevalence of anemia and utilization rate of ESAs in Japanese patients with CKD using data from a nationwide cohort study. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
62. Effects of BMP7 produced by group 2 innate lymphoid cells on adipogenesis.
- Author
-
Miyajima, Yurina, Ealey, Kafi N, Motomura, Yasutaka, Mochizuki, Miho, Takeno, Natsuki, Yanagita, Motoko, Economides, Aris N, Nakayama, Manabu, Koseki, Haruhiko, and Moro, Kazuyo
- Subjects
- *
INNATE lymphoid cells , *BONE morphogenetic proteins , *ADIPOSE tissues , *CELL differentiation , *HELMINTHIASIS - Abstract
Group 2 innate lymphoid cells (ILC2s) are type 2 cytokine-producing cells that have important roles in helminth infection and allergic inflammation. ILC2s are tissue-resident cells, and their phenotypes and roles are regulated by tissue-specific environmental factors. While the role of ILC2s in the lung, intestine and bone marrow has been elucidated in many studies, their role in adipose tissues is still unclear. Here, we report on the role of ILC2-derived bone morphogenetic protein 7 (BMP7) in adipocyte differentiation and lipid accumulation. Co-culture of fat-derived ILC2s with pluripotent mesenchymal C3H10T1/2 cells and committed white preadipocyte 3T3-L1 cells resulted in their differentiation to adipocytes and induced lipid accumulation. Co-culture experiments using BMP7-deficient ILC2s revealed that BMP7, produced by ILC2s, induces differentiation into brown adipocytes. Our results demonstrate that BMP7, produced by ILC2s, affects adipocyte differentiation, particularly in brown adipocytes. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
63. J-CKD-DB: a nationwide multicentre electronic health record-based chronic kidney disease database in Japan.
- Author
-
Nakagawa, Naoki, Sofue, Tadashi, Kanda, Eiichiro, Nagasu, Hajime, Matsushita, Kunihiro, Nangaku, Masaomi, Maruyama, Shoichi, Wada, Takashi, Terada, Yoshio, Yamagata, Kunihiro, Narita, Ichiei, Yanagita, Motoko, Sugiyama, Hitoshi, Shigematsu, Takashi, Ito, Takafumi, Tamura, Kouichi, Isaka, Yoshitaka, Okada, Hirokazu, Tsuruya, Kazuhiko, and Yokoyama, Hitoshi
- Subjects
- *
ELECTRONIC health records , *INFORMATION retrieval , *PROTEINURIA , *DATABASES - Abstract
The Japan Chronic Kidney Disease (CKD) Database (J-CKD-DB) is a large-scale, nation-wide registry based on electronic health record (EHR) data from participating university hospitals. Using a standardized exchangeable information storage, the J-CKD-DB succeeded to efficiently collect clinical data of CKD patients across hospitals despite their different EHR systems. CKD was defined as dipstick proteinuria ≥1+ and/or estimated glomerular filtration rate <60 mL/min/1.73 m2 base on both out- and inpatient laboratory data. As an initial analysis, we analyzed 39,121 CKD outpatients (median age was 71 years, 54.7% were men, median eGFR was 51.3 mL/min/1.73 m2) and observed that the number of patients with a CKD stage G1, G2, G3a, G3b, G4 and G5 were 1,001 (2.6%), 2,612 (6.7%), 23,333 (59.6%), 8,357 (21.4%), 2,710 (6.9%) and 1,108 (2.8%), respectively. According to the KDIGO risk classification, there were 30.1% and 25.5% of male and female patients with CKD at very high-risk, respectively. As the information from every clinical encounter from those participating hospitals will be continuously updated with an anonymized patient ID, the J-CKD-DB will be a dynamic registry of Japanese CKD patients by expanding and linking with other existing databases and a platform for a number of cross-sectional and prospective analyses to answer important clinical questions in CKD care. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
64. Autophagy protects kidney from phosphate-induced mitochondrial injury.
- Author
-
Fujimura, Ryuta, Yamamoto, Takeshi, Takabatake, Yoshitsugu, Takahashi, Atsushi, Namba-Hamano, Tomoko, Minami, Satoshi, Sakai, Shinsuke, Matsuda, Jun, Hesaka, Atsushi, Yonishi, Hiroaki, Nakamura, Jun, Matsui, Isao, Matsusaka, Taiji, Niimura, Fumio, Yanagita, Motoko, and Isaka, Yoshitaka
- Subjects
- *
DISEASE complications , *UBIQUITINATION , *CHRONIC kidney failure , *KIDNEYS , *KIDNEY injuries , *WOUNDS & injuries , *KIDNEY diseases - Abstract
Hyperphosphatemia is a common complication in patients with advanced chronic kidney disease (CKD) as well as an increased risk of cardiovascular mortality; however, the molecular mechanisms of phosphate-mediated kidney injury are largely unknown. Autophagy is a lysosomal degradation system, which plays protective roles against kidney diseases. Here, we studied the role of autophagy in kidney proximal tubular cells (PTECs) during phosphate overload. Temporal cessation of autophagy in drug-induced PTEC-specific autophagy-deficient mice that were fed high phosphate diet induced mild cytosolic swelling and an accumulation of SQSTM1/p62-and ubiquitin-positive protein aggregates in PTECs, indicating that phosphate overload requires enhanced autophagic activity for the degradation of increasing substrate. Morphological and biochemical analysis demonstrated that high phosphate activates mitophagy in PTECs in response to oxidative stress. PTEC-specific autophagy-deficient mice receiving heminephrectomy and autophagy-deficient cultured PTECs exhibited mitochondrial dysfunction, increased reactive oxygen species production, and reduced ATP production in response to phosphate overload, suggesting that high phosphate-induced autophagy counteracts mitochondrial injury and maintains cellular bioenergetics in PTECs. Thus, potentiating autophagic activity could be a therapeutic option for suppressing CKD progression during phosphate overload. • Hyperphosphatemia is a complication in patients with advanced chronic kidney disease. • Phosphate overload induces mitochondrial dysfunction and oxidative stress in kidney. • Phosphate overload activates autophagy in kidney proximal tubular cells. • Phosphate-induced autophagy alleviates mitochondrial injury and cellular damage. • Potentiating autophagic activity may suppress phosphate-mediated kidney injury. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
65. Optimal follow-up intervals for different stages of chronic kidney disease: a prospective observational study.
- Author
-
Hirano, Keita, Kobayashi, Daiki, Kohtani, Naoto, Uemura, Yukari, Ohashi, Yasuo, Komatsu, Yasuhiro, Yanagita, Motoko, and Hishida, Akira
- Subjects
- *
CLINICAL trial registries , *KIDNEY diseases , *CHRONIC diseases , *LONGITUDINAL method , *TIME perception - Abstract
Background: Chronic kidney disease (CKD) is a public health challenge; however, evidence-based, optimal follow-up intervals for patients with CKD have not been identified. This study aimed to identify appropriate follow-up intervals for different stages of CKD. Methods: We studied 2682 patients with CKD. The number of patients experiencing a 50% increase in creatinine and those reaching end-stage renal failure were examined on the basis of their CKD stage. The renal function testing interval was defined as the estimated time for 0.1% of the patients with CKD to have a composite renal outcome, after adjusting for clinical risk factors. Transitions from CKD stage-based subgroups were analyzed using parametric cumulative incidence models. Other sensitivity analyses involved estimation of the time to renal event occurrence for 1% of patients. Results: Of the 913 patients (34%) who had a composite renal event, 29 had stage 3A (10.5%), 151 had stage 3B (16.3%), 429 had stage 4 (41.0%), and 304 had stage 5 CKD (70.9%). The estimated renal function testing intervals for patients with CKD were 6.0 months for stage 3A, 3.4 months for stage 3B, 2.0 months for stage 4, and 1.2 months for stage 5. Conclusions: The optimal follow-up intervals were longer for patients with lower CKD stages. These estimates are longer than those recommended by the current guidelines and serve as a reference for nephrologists in selecting an appropriate follow-up interval for each patient. Trial registration: UMIN clinical trial registry number: UMIN000020038. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
66. Everolimus delayed and suppressed cytomegalovirus DNA synthesis, spread of the infection, and alleviated cytomegalovirus infection.
- Author
-
Tan, Long, Sato, Noriaki, Shiraki, Atsuko, Yanagita, Motoko, Yoshida, Yoshihiro, Takemura, Yoshinori, and Shiraki, Kimiyasu
- Subjects
- *
EVEROLIMUS , *CYTOMEGALOVIRUSES , *DNA synthesis , *RAPAMYCIN , *VIRAL adsorption - Abstract
Abstract Everolimus is an inhibitor of mammalian target of rapamycin (mTOR) and reduces the risk of cytomegalovirus (CMV) infection in transplant recipients. Everolimus inhibits mTOR complex 1, which regulates factors involved in several crucial cellular functions and is required for CMV replication. However, it is not clear how everolimus regulates CMV replication and prevents and alleviates CMV infection. Effects of everolimus on CMV infection, spread, and DNA synthesis and release from infected cells were assessed by plaque formation, infectious centre assay, real-time PCR of infected cells, and culture supernatant in CMV-infected cultures with and without everolimus. Everolimus enhanced plaque formation by 3.6 times, but the size of the plaques was reduced to 36.4% of untreated cultures in the absence of a pretreatment period. Everolimus reduced viral adsorption but enhanced the replication efficiency of inoculated virus, resulting in an increase in plaque number in the early phase of infection. Preinfection treatment of cells with everolimus efficiently exhibited its antiviral efficacy, and everolimus delayed and suppressed viral DNA synthesis and release from infected cells. Everolimus had suppressed the spread of infection and reduced the number of total infected cells to 40% of untreated cells on day 9, indicating reduction of the size of CMV lesions to one-sixth in 2–3 replication cycles. Preinfection treatment of the cells with everolimus augmented its suppressive effect on CMV infection and replication. Everolimus reduced the total number of infected cells and limited the CMV lesions, and this reduction in the spread of CMV infection would alleviate CMV infection in transplant recipients. Highlights • Everolimus is an inhibitor of mammalian target of rapamycin (mTOR). • Everolimus reduces the risk of cytomegalovirus infection in transplant recipients. • Everolimus suppressed viral adsorption and delayed and suppressed DNA synthesis and release. • Everolimus suppressed the spread of infection and reduced the number of infected cells to 40% of untreated cells on day 9. • Reduction in the spread of CMV infection would alleviate CMV infection in transplant recipients. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
67. Tocilizumab prevents renal function of a patient with diabetic kidney disease: case report.
- Author
-
Toriu, Naoya, Yamanouchi, Masayuki, Hiramatsu, Rikako, Hayami, Noriko, Hoshino, Junichi, Sekine, Akinari, Kawada, Masahiro, Hasegawa, Eiko, Suwabe, Tatsuya, Sumida, Keiichi, Sawa, Naoki, Takaichi, Kenmei, Yanagita, Motoko, and Ubara, Yoshifumi
- Subjects
- *
TOCILIZUMAB , *KIDNEY function tests , *PEOPLE with diabetes , *KIDNEY disease treatments , *RHEUMATOID arthritis diagnosis - Abstract
Diabetic kidney disease (DKD) is the major cause of end stage renal disease. Despite the best current treatment, it is difficult to stop the progression of DKD. We report a 77-year-old Japanese man in whom rheumatoid arthritis (RA) was diagnosed at the age of 30 years, followed by type 2 diabetes mellitus (T2DM) at age 55. His haemoglobin A1c (HbA1c) was around 7-9%, even after starting insulin therapy. His renal function deteriorated steadily, with the estimated glomerular filtration rate (eGFR) decreasing by 2 mL/min/1.73 m2 per year to reach 29 mL/min/1.73 m2 (consistent with stage IV diabetic kidney disease) at age 69. Because RA was poor controlled with a DAS28-ESR of 4.46, HAQ of 0.375, and SDAI of 8.6, treatment with tocilizumab (an interleukin-6 receptor antibody) was initiated. Thereafter, control of RA improved, but HbA1c stayed in the range of 7-9%. However, eGFR remained around 30 ml/min/1.73 m2 even after 8 years. This case indicates that interleukin-6 might contribute to exacerbation of renal dysfunction, since IL-6 receptor blockade prevented deterioration of renal function in this patient with RA and diabetic kidney disease. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
68. Dialysis physicians’ referral behaviors for hemodialysis patients suspected of having cancer: A vignette-based questionnaire study.
- Author
-
Fukuma, Shingo, Kimachi, Miho, Omae, Kenji, Kataoka, Yuki, Yamazaki, Hajime, Muto, Manabu, Akizawa, Tadao, Yanagita, Motoko, and Fukuhara, Shunichi
- Subjects
- *
HEMODIALYSIS patients , *CANCER diagnosis , *HEALTH behavior , *PATIENT acceptance of health care , *AGE factors in disease - Abstract
Background: Although cancer management in dialysis patients has become a commonly encountered issue, known as “onco-nephrology”, few evidence-based clinical recommendations have been proposed. Here, we examined the variation in referral behaviors adopted by dialysis physicians on encountering dialysis patients with signs/symptoms suggestive of cancer. Methods: We conducted a vignette-based study in August 2015. We sent a 14-page questionnaire to 191 dialysis physicians, including the representative dialysis facilities participating in a Japanese dialysis cohort (the Japan Dialysis Outcomes and Practice Patterns Study). Using vignette scenarios for respiratory, digestive, and urological areas, we assessed the referral behaviors (expert referral or not) adopted by dialysis physicians on encountering dialysis patients with symptoms suggestive of cancer. Each scenario contained three patient functional factors: age (60 or 75 years), performance status (PS 0 or 1), and cognitive dysfunction (absence or presence). We examined the association between physician factors, patient factors, and referral behaviors. Results: We obtained 94 replies (response rate: 49.2%). For the respiratory scenarios, 38.3% and 51.9% of physicians reported watchful waiting when encountering bilateral and unilateral pleural effusion, respectively. In digestive and urologic scenarios, most physicians (>85%) selected expert referral. We detected differences in referral behaviors between scenarios with different cancer biological factors. However, we found consistency in referral behaviors within the same scenario, even with different patient functional factors (intra-class correlation coefficients within each scenario all >0.7). Conclusions: Physicians’ referral behaviors for dialysis patients suspected of having cancer vary for different cancer biological factors (probability of having cancer). However, the referral behaviors are similar for different patient functional factors (age, PS, and cognitive dysfunction). [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
69. Guanylyl Cyclase A in Both Renal Proximal Tubular and Vascular Endothelial Cells Protects the Kidney against Acute Injury in Rodent Experimental Endotoxemia Models.
- Author
-
Kitamura, Hiroaki, Nakano, Daisuke, Sawanobori, Yoshiharu, Asaga, Takehiko, Yokoi, Hideki, Yanagita, Motoko, Mukoyama, Masashi, Tokudome, Takeshi, Kangawa, Kenji, Shirakami, Gotaro, and Nishiyama, Akira
- Abstract
What We Already Know About This Topic: WHAT THIS ARTICLE TELLS US THAT IS NEW: BACKGROUND:: Natriuretic peptides are used, based on empirical observations, in intensive care units as antioliguric treatments. We hypothesized that natriuretic peptides prevent lipopolysaccharide-induced oliguria by activating guanylyl cyclase A, a receptor for natriuretic peptides, in proximal tubules and endothelial cells.Methods: Normal Sprague-Dawley rats and mice lacking guanylyl cyclase A in either endothelial cells or proximal tubular cells were challenged with lipopolysaccharide and assessed for oliguria and intratubular flow rate by intravital imaging with multiphoton microscopy.Results: Recombinant atrial natriuretic peptide efficiently improved urine volume without changing blood pressure after lipopolysaccharide challenge in rats (urine volume at 4 h, lipopolysaccharide: 0.6 ± 0.3 ml · kg · h; lipopolysaccharide + fluid resuscitation: 4.6 ± 2.0 ml · kg · h; lipopolysaccharide + fluid resuscitation + atrial natriuretic peptide: 9.0 ± 4.8 ml · kg · h; mean ± SD; n = 5 per group). Lipopolysaccharide decreased glomerular filtration rate and slowed intraproximal tubular flow rate, as measured by in vivo imaging. Fluid resuscitation restored glomerular filtration rate but not tubular flow rate. Adding atrial natriuretic peptide to fluid resuscitation improved both glomerular filtration rate and tubular flow rate. Mice lacking guanylyl cyclase A in either proximal tubules or endothelium demonstrated less improvement of tubular flow rate when treated with atrial natriuretic peptide, compared with control mice. Deletion of endothelial, but not proximal tubular, guanylyl cyclase A augmented the reduction of glomerular filtration rate by lipopolysaccharide.Conclusions: Both endogenous and exogenous natriuretic peptides prevent lipopolysaccharide-induced oliguria by activating guanylyl cyclase A in proximal tubules and endothelial cells. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
70. Sequential renal biopsy in a patient with lupus nephritis and fingerprint deposits: a case report.
- Author
-
Toriu, Naoya, Hiramatsu, Rikako, Mizuno, Hiroki, Ikuma, Daisuke, Sekine, Akinari, Hayami, Noriko, Sumida, Keiichi, Yamanouchi, Masayuki, Hasegawa, Eiko, Hoshino, Junichi, Sawa, Naoki, Takaichi, Kenmei, Ohashi, Kenichi, Fujii, Takeshi, Yanagita, Motoko, and Ubara, Yoshifumi
- Subjects
- *
RENAL biopsy , *SYSTEMIC lupus erythematosus , *KIDNEY diseases , *DNA fingerprinting - Abstract
We report a 38-year-old Japanese man in whom lupus membranous nephropathy was diagnosed by renal biopsy. Steroid therapy was initiated, followed by cyclophosphamide and calcineurin inhibitors. Although serum markers for the activity of lupus nephritis (LN) showed improvement, his renal function gradually declined. During this period, renal biopsy was repeated three times whenever proteinuria increased, revealing progression of lupus membranous nephropathy with an increase of epithelial immune deposits. Electron microscopy of the first biopsy specimen did not clearly show subepithelial fingerprint deposits, but these structures were better-defined at the second biopsy. The number of bands in the deposits was larger at the third biopsy and increased to a maximum of 25 at the fourth biopsy. These findings indicate that fingerprint deposits may be related to chronic change or disease activity of lupus membranous nephropathy, but the changes of these deposits were not consistent with those of serum markers of LN disease activity. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
71. Deletion of connective tissue growth factor ameliorates peritoneal fibrosis by inhibiting angiogenesis and inflammation.
- Author
-
Toda, Naohiro, Mori, Kiyoshi, Kasahara, Masato, Koga, Kenichi, Ishii, Akira, Mori, Keita P, Osaki, Keisuke, Mukoyama, Masashi, Yanagita, Motoko, and Yokoi, Hideki
- Subjects
- *
CONNECTIVE tissue growth factor , *RETROPERITONEAL fibrosis , *NEOVASCULARIZATION , *INFLAMMATION , *LABORATORY mice - Abstract
Background. Connective tissue growth factor (CTGF/CCN2) regulates the signalling of other growth factors and promotes fibrosis. CTGF is increased in mice and humans with peritoneal fibrosis. Inhibition of CTGF has not been examined as a potential therapeutic target for peritoneal fibrosis because systemic CTGF knockout mice die at the perinatal stage. Methods. To study the role of CTGF in peritoneal fibrosis of adult mice, we generated CTGF conditional knockout (cKO) mice by crossing CTGF floxed mice with RosaCreERT2 mice. We administered tamoxifen to Rosa-CTGF cKO mice to delete the CTGF gene throughout the body. We induced peritoneal fibrosis by intraperitoneal injection of chlorhexidine gluconate (CG) in wild-type and Rosa-CTGF cKO mice. Results. Induction of peritoneal fibrosis in wild-type mice increased CTGF expression and produced severe thickening of the peritoneum. In contrast, CG-treated Rosa-CTGF cKO mice exhibited reduced thickening of the peritoneum. Peritoneal equilibration test revealed that the excessive peritoneal small-solute transport in CG-treated wild-type mice was normalized by CTGF deletion. CG-treated Rosa-CTGF cKO mice exhibited a reduced number of aSMA-, Ki67-, CD31- and MAC-2-positive cells in the peritoneum. Analyses of peritoneal mRNA showed that CG-treated Rosa-CTGF cKO mice exhibited reduced expression of Cd68, Acta2 (aSMA), Pecam1 (CD31) and Vegfa. Conclusions. These results indicate that a deficiency of CTGF can reduce peritoneal thickening and help to maintain peritoneal function by reducing angiogenesis and inflammation in peritoneal fibrosis. These results suggest that CTGF plays an important role in the progression of peritoneal fibrosis. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
72. Guidelines for treatment of renal injury during cancer chemotherapy 2016.
- Author
-
Horie, Shigeo, Oya, Mototsugu, Nangaku, Masaomi, Yasuda, Yoshinari, Komatsu, Yasuhiro, Yanagita, Motoko, Kitagawa, Yuko, Kuwano, Hiroyuki, Nishiyama, Hiroyuki, Ishioka, Chikashi, Takaishi, Hiromasa, Shimodaira, Hideki, Mogi, Akira, Ando, Yuichi, Matsumoto, Koji, Kadowaki, Daisuke, and Muto, Satoru
- Subjects
- *
CANCER treatment , *CANCER chemotherapy , *NEPHROTOXICOLOGY , *GLOMERULAR filtration rate , *KIDNEY injuries - Published
- 2018
- Full Text
- View/download PDF
73. Chronic Kidney Disease Predicts Survival in Patients with Idiopathic Pulmonary Fibrosis.
- Author
-
Ikezoe, Kohei, Handa, Tomohiro, Tanizawa, Kiminobu, Yokoi, Hideki, Kubo, Takeshi, aihara, Kensaku, Sokai, akihiko, Nakatsuka, Yoshinari, Hashimoto, Seishu, Uemasu, Kiyoshi, Sato, Susumu, Muro, Shigeo, Nagai, Sonoko, Yanagita, Motoko, Chin, Kazuo, Hirai, Toyohiro, Taguchi, Yoshio, and Mishima, Michiaki
- Subjects
- *
LUNG physiology , *AGE distribution , *CHI-squared test , *CHRONIC kidney failure , *DIFFUSION , *GLOMERULAR filtration rate , *PROGNOSIS , *RESEARCH funding , *PULMONARY function tests , *SURVIVAL , *WALKING , *COMORBIDITY , *CONTROL groups , *ACQUISITION of data , *DISEASE prevalence , *PROPORTIONAL hazards models , *PATIENT selection , *DATA analysis software , *DESCRIPTIVE statistics , *IDIOPATHIC pulmonary fibrosis , *KAPLAN-Meier estimator , *SYMPTOMS , *DIAGNOSIS - Abstract
Background: The prevalence of chronic kidney disease (CKD) increases with age as with idiopathic pulmonary fibrosis (IPF). Objectives: We assessed the prevalence of CKD (stages 3-5) and investigated the relationship of CKD to clinical features and outcomes in patients with IPF. Methods: This study comprised 123 patients with IPF; 61 subjects with chronic obstructive pulmonary disease (COPD), which was reportedly associated with CKD, were also enrolled as a disease control. CKD (stages 3-5) was defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m². Results: Thirty-seven patients (30%) with IPF and 14 controls (23%) with COPD were diagnosed with CKD, and these frequencies were not significantly different. The patients with IPF and CKD were older (p < 0.01) and had a higher frequency of hypertension (p = 0.048) and ischemic heart disease (p = 0.02) than those with IPF but without CKD. Furthermore, the diffusing capacity of the lung for carbon monoxide (DLCO) and the 6-min walking distance in the patients with CKD were significantly lower (40.0 ± 13.2 vs. 45.9 ± 14.4%, p = 0.04, and 416 ± 129 vs. 474 ± 84 m, p = 0.01, respectively) than in the patients without CKD. The outcome of the patients with CKD showed significantly worse survival compared with the patients without CKD (p = 0.04). Moreover, eGFR remained an independent predictor of survival after adjusting for age and pulmonary function data. Conclusion: A substantial percentage of IPF patients have CKD. CKD with a low eGFR was associated with decreased survival in IPF. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
74. Dietary Sodium Restriction Reduces Nocturnal Urine Volume and Nocturnal Polyuria Index in Renal Allograft Recipients With Nocturnal Polyuria.
- Author
-
Okumura, Yoshinaga, Asai, Kanae, Kobayashi, Takashi, Miyata, Hitomi, Tanaka, Yukari, Okada, Yoshiyuki, Sakai, Kaoru, Kamba, Tomomi, Tsuji, Hidemi, Shide, Kenichiro, Nagashima, Kazuaki, Yanagita, Motoko, Inagaki, Nobuya, Ogawa, Osamu, and Negoro, Hiromitsu
- Subjects
- *
KIDNEY surgery , *HOMOGRAFTS , *NUTRITION counseling , *DIETITIANS , *SODIUM content of food , *KIDNEY transplantation , *LONGITUDINAL method , *QUESTIONNAIRES , *SALT-free diet , *URINATION disorders , *URINE , *TREATMENT effectiveness , *PREVENTION - Abstract
Objective: To investigate whether sodium restriction alters the nocturnal urine volume (NUV) and the ratio of NUV to 24-hour urine of renal allograft recipients (RARs).Materials and Methods: This prospective, single-center study analyzed 38 of the 59 RARs who were followed up for more than 6 months in our hospital. All patients underwent 3 sessions of dietary counseling performed by a board-certified dietitian. Before and after these 3 sessions, 24-hour urine samples were collected, along with voiding frequency volume charts.Results: Of the 38 included RARs, 23 (60.5%) were diagnosed as having nocturnal polyuria (NP, NUV >10 mL/kg). After counseling the RARs with NP, their 24-hour sodium excretion was reduced from 169.5 to 125.6 mEq (P = .0066), their NUV from 862 to 709 mL (P = .021), and the ratio of NUV to 24-hour urine volume from 38.9% to 33.0% (P = .023). In contrast, these parameters were not significantly changed by dietary counseling in RARs without NP. Reduced sodium excretion and decreased NUV were significantly correlated (Spearman rho = 0.45, P = .005).Conclusion: Excess intake of sodium is considered a cause of NP in RARs. Dietary counseling on sodium restriction is effective in reducing NUV in RARs. Prospective studies are needed to evaluate the general population with NP. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
75. Development of quality indicators for care of chronic kidney disease in the primary care setting using electronic health data: a RAND-modified Delphi method.
- Author
-
Fukuma, Shingo, Shimizu, Sayaka, Niihata, Kakuya, Sada, Ken-ei, Yanagita, Motoko, Hatta, Tsuguru, Nangaku, Masaomi, Katafuchi, Ritsuko, Fujita, Yoshiro, Koizumi, Junji, Koizumi, Shunzo, Kimura, Kenjiro, Fukuhara, Shunichi, and Shibagaki, Yugo
- Subjects
- *
CHRONIC kidney failure , *HEALTH status indicators , *ELECTRONIC health records , *PRIMARY care , *DELPHI method - Abstract
Background: The prevalence of chronic kidney disease (CKD) has recently increased, and maintaining high quality of CKD care is a major factor in preventing end-stage renal disease. Here, we developed novel quality indicators for CKD care based on existing electronic health data. Methods: We used a modified RAND appropriateness method to develop quality indicators for the care of non-dialysis CKD patients, by combining expert opinion and scientific evidence. A multidisciplinary expert panel comprising six nephrologists, two primary care physicians, one diabetes specialist, and one rheumatologist assessed the appropriateness of potential indicators extracted from evidence-based clinical guidelines, in accordance with predetermined criteria. We developed novel quality indicators through a four-step process: selection of potential indicators, first questionnaire round, face-to-face meeting, and second questionnaire round. Results: Ten expert panel members evaluated 19 potential indicators in the first questionnaire round, of which 7 were modified, 12 deleted, and 4 newly added during subsequent face-to-face meetings, giving a final total of 11 indicators. Median rate of these 11 indicators in the final set was at least 7, and percentages of agreement exceeded 80 % for all but one indicator. All indicators in the final set can be measured using only existing electronic health data, without medical record review, and 9 of 11 are process indicators. Conclusion: We developed 11 quality indicators to assess quality of care for non-dialysis CKD patients. Strengths of the developed indicators are their applicability in a primary care setting, availability in daily practice, and emphasis on modifiable processes. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
76. Accumulation of alpha-fluoro-beta-alanine and fluoro mono acetate in a patient with 5-fluorouracil-associated hyperammonemia.
- Author
-
Nishikawa, Yoshitaka, Funakoshi, Taro, Horimatsu, Takahiro, Miyamoto, Shin'ichi, Matsubara, Takeshi, Yanagita, Motoko, Nakagawa, Shunsaku, Yonezawa, Atsushi, Matsubara, Kazuo, and Muto, Manabu
- Subjects
- *
ACETATES , *HYPERAMMONEMIA , *CANCER chemotherapy , *PHARMACOKINETICS , *COLON cancer , *METABOLIC disorder treatment , *THERAPEUTIC use of antimetabolites , *ACETIC acid , *ALANINE , *AMMONIA , *ANTIMETABOLITES , *ANTINEOPLASTIC agents , *COLON tumors , *COMBINED modality therapy , *DIABETIC nephropathies , *FLUOROURACIL , *HEMODIALYSIS , *METABOLIC disorders , *DISEASE complications , *THERAPEUTICS ,RECTUM tumors - Abstract
Purpose: High-dose 5-fluorouracil (5-FU) containing chemotherapy occasionally causes hyperammonemia and can be lethal. However, the mechanism of 5FU-associated hyperammonemia has not been known. The aim of this study was to reveal the pharmacokinetics of 5-FU-associated hyperammonemia in a recurrent colorectal cancer patient with end-stage renal disease (ESRD).Methods: We experienced a case of hyperammonemia during mFOLFOX6 plus bevacizumab therapy for recurrent colorectal cancer. He was a dialyzed patient due to diabetic nephropathy and was registered to prospective blood sampling for pharmacokinetics analysis during chemotherapy. Blood concentrations of 5-FU and its catabolites were determined by inductively coupled plasma-mass spectrometry.Results: The patient developed hyperammonemia encephalopathy 41 h after the initiation of continuous 5-FU infusion (on the third day). Before onset of hyperammonemia encephalopathy, serum alpha-fluoro-beta-alanine (FBAL, 59.2 µg/ml) and fluoro mono acetate (FMA, 905.8 ng/ml) were gradually increased. After hemodialysis for hyperammonemia, FBAL and FMA were collaterally decreased and his symptom was improved. Other intermediate catabolites of 5-FU, dihydrofluorouracil, and alpha-fluoro-beta-ureidopropionic acid were not changed.Conclusion: We found increases of serum FBAL and FMA under the condition of hyperammonemia in the patient with ESRD during mFOLFOX6 plus bevacizumab therapy. This research supported the hypothesis that impairment of tricarboxylic acid (TCA) cycle by FMA would cause 5-FU-associated hyperammonemia. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
77. Estimation of the number of histological diagnosis for IgG4-related kidney disease referred to the data obtained from the Japan Renal Biopsy Registry (J-RBR) questionnaire and cases reported in the Japanese Society of Nephrology Meetings.
- Author
-
Nakashima, Hitoshi, Kawano, Mitsuhiro, Saeki, Takako, Ubara, Yoshifumi, Hisano, Satoshi, Nagata, Michio, Zen, Yoh, Yanagita, Motoko, Yamaguchi, Yutaka, Nishi, Shinichi, and Saito, Takao
- Subjects
- *
KIDNEY disease diagnosis , *IMMUNOGLOBULIN G , *REGIONAL distribution centers , *SURVEYS , *HISTOLOGICAL techniques - Abstract
Background: More than 2 years have passed since the proposal of the diagnostic criteria for IgG4-related kidney disease (IgG4-RKD). The aim of this study was to estimate the number of histological diagnosis for IgG4-RKD throughout Japan and to clarify the regional distribution of the development of this disease. Methods: A questionnaire was supplied to 140 research facilities registered in the Japan Renal Biopsy Registry (J-RBR). The items of the questionnaire were the total number of renal biopsies performed and the number of cases diagnosed as IgG4-RKD in 2012 and 2013 at each facility. Age, sex, and diagnosis category were also included for the IgG4-RKD cases. The geographic distribution of the disease development was evaluated using clinical case reports presented at the Eastern/Western regional meeting of the Japanese Society of Nephrology during the 15 years following 2001. Results: Forty-seven facilities completed the questionnaire, resulting in a collection rate of 34 %. The total numbers of renal biopsies in 2012 and 2013 were 3387 and 3591, respectively. Forty-seven of these cases (24 in 2012 and 23 in 2013) were diagnosed as IgG4-RKD. The frequency of development of IgG4-RKD per one million over 40-year-old individuals during these 15 years varied between 0.9 and 3.1, depending on Japanese geographic region of Japan. Conclusion: The results of the present survey indicate that the number of diagnosis for IgG4-RKD is approximately 130 cases per year throughout Japan, and no regional differences in disease frequency appear to exist. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
78. Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis.
- Author
-
Kitagori, Koji, Yoshifuji, Hajime, Oku, Takuma, Sasaki, Chiyomi, Miyata, Hitomi, Mori, Keita P., Nakajima, Toshiki, Ohmura, Koichiro, Kawabata, Daisuke, Yukawa, Naoichiro, Imura, Yoshitaka, Murakami, Kosaku, Nakashima, Ran, Usui, Takashi, Fujii, Takao, Sakai, Kaoru, Yanagita, Motoko, Hirayama, Yoshitaka, and Mimori, Tsuneyo
- Subjects
- *
SYSTEMIC lupus erythematosus treatment , *SYSTEMIC lupus erythematosus diagnosis , *DIABETIC nephropathies , *URINALYSIS , *OSTEOPONTIN , *THERAPEUTICS - Abstract
We assessed the utility of two forms of osteopontin (OPN), OPN full and its cleaved form (OPN N-half), in plasma and urine as markers of disease activity in lupus nephritis (LN). Samples were collected from patients with systemic lupus erythematosus (SLE) (LN: N = 29, non-LN: N = 27), IgA nephropathy (IgAN) (N = 14), minimal change nephrotic syndrome (MCNS) (N = 5), diabetic nephropathy (DN) (N = 14) and healthy volunteers (HC) (N = 17). While there was no significant difference in urine OPN full concentration between groups, urine OPN N-half concentration was significantly higher in patients with LN than HC (p < 0.05). Moreover, urine OPN N-half was higher in LN patients with overt proteinuria (urine protein/creatinine ratio: P/C > 0.5) than LN patients with minimal proteinuria (P/C < 0.5, p < 0.0001), and also higher than in DN patients with overt proteinuria (P/C > 0.5, p < 0.01). Urine thrombin activity correlated with urine OPN N-half concentration (p < 0.0001), but not with urine OPN full concentration. These results suggest that urine OPN N-half concentration reflects renal inflammation. Thus, urine OPN N-half may be a novel disease activity marker for LN. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
79. Antagonistic Functions of USAG-1 and RUNX2 during Tooth Development.
- Author
-
Togo, Yumiko, Takahashi, Katsu, Saito, Kazuyuki, Kiso, Honoka, Tsukamoto, Hiroko, Huang, Boyen, Yanagita, Motoko, Sugai, Manabu, Harada, Hidemitsu, Komori, Toshihisa, Shimizu, Akira, MacDougall, Mary, and Bessho, Kazuhisa
- Subjects
- *
TEETH abnormalities , *DENTITION , *INCISORS , *SUPERNUMERARY teeth , *LABORATORY mice - Abstract
Supernumerary teeth and tooth agenesis are common morphological anomalies in humans. We previously obtained evidence that supernumerary maxillary incisors form as a result of the successive development of the rudimentary maxillary incisor tooth germ in Usag-1 null mice. The development of tooth germs is arrested in Runx2 null mice, and such mice also exhibit lingual epithelial buds associated with the upper molars and incisors. The aim of this study is to investigate the potential crosstalk between Usag-1 and Runx2 during tooth development. In the present study, three interesting phenomena were observed in double null Usag-1-/-/Runx2-/- mice: the prevalence of supernumerary teeth was lower than in Usag-1 null mice; tooth development progressed further compared than in Runx2 null mice; and the frequency of molar lingual buds was lower than in Runx2 null mice. Therefore, we suggest that RUNX2 and USAG-1 act in an antagonistic manner. The lingual bud was completely filled with odontogenic epithelial Sox2-positive cells in the Usag-1+/+/Runx2-/- mice, whereas almost no odontogenic epithelial Sox2-positive cells contributed to supernumerary tooth formation in the rudimentary maxillary incisors of the Usag-1-/-/Runx2+/+ mice. Our findings suggest that RUNX2 directly or indirectly prevents the differentiation and/or proliferation of odontogenic epithelial Sox2-positive cells. We hypothesize that RUNX2 inhibits the bone morphogenetic protein (BMP) and/or Wnt signaling pathways regulated by USAG-1, whereas RUNX2 expression is induced by BMP signaling independently of USAG-1. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
80. Advanced Glycation Endprocucts Is Involved in the Development of Age-Associated Glomeruloselerosis through Growth Arrest Specific Gene 6.
- Author
-
Matsubara, Takeshi, Nagai, Kojiro, Yanagita, Motoko, Mima, Akira, Kanamori, Hiroshi, Sumi, Eriko, Iehara, Noriyuki, Fukatsu, Atsushi, Kita, Toru, Doi, Toshio, and Arai, Hidenori
- Subjects
- *
GLUCOSE , *KIDNEY diseases , *GROWTH factors , *DIABETIC nephropathies , *DIABETES complications , *AGING , *LABORATORY mice - Abstract
Advanced glycation end products (AGEs) contribute to kidney disease due to diabetes or aging by stimulating glomerular mesangial cells, which promote the expression of various growth factors. Further, aging is characterized by renal structural abnormalities, such as glomerulosclerosis, resembling those observed in diabetes. However, the relationship between AGEs, growth factors, and kidney lesions remains largely uncharacterized. We have reported that growth arrest-specific gene 6 (Gas6), a new mitogen for mesangial cells, plays a key role for the development of diabetic nephropathy. In this study, we examine whether the link between AGEs and Gas6 is involved in the development of age-associated glomerular lesions. First, to examine the relationship between AGEs, Gas6 and aging, the isolation of glomeruli was performed from young (1 month) and aged (12months) mice, and the expression of Gas6 in isolated glomeruli was quantified by real-time PCR. Renal accumulation of AGEs (carboxyethyl-lysine) was also quantified by dot blot assay of kidney lysates. Glomerular expression of Gas6 was increased by 2 folds in aged mice. Renal AGE accumulation was also increased with age. Next, Gas6 knock out (KO) and wild type (WT) mice were studied at 3, 12, and 24 months (n=6 animals/group). Glomerular surface area and mesangial area were also progressively increased in WT mice with age by morphometric analyses. However, in KO mice, the increase of glomerular surface area was suppressed at 12months, and mesangial expansion was significantly ameliorated at 24 months compared with age-matched WT mice, whereas there is no difference in the levels of renal AGEs between age-matched WT and KO mice. Further, to find a link between AGEs and Gas6, we examined whether AGEs induce Gas6 in mesangial cells and checked the transcriptional activity of type IV collagen (Co14), which is the major component of extracellular matrix in glomemlosclerosis, under AGE stimulation in mesangial cells both from WT and KO mice. AGEs induced Gas6 in mesangial cells from WT mice. AGEs increased the transcriptional activity of Co14 in mesangial cells from WT mice, which is significantly suppressed in those from KO mice. These results suggest that Gas6 is involved in the development of age-associated glomerular damages via AGE accumulation, and that Gas6 could be a novel therapeutic target for aging kidney. [ABSTRACT FROM AUTHOR]
- Published
- 2007
81. Establishment of Nephrin Reporter Mice and Use for Chemical Screening.
- Author
-
Tsuchida, Junichi, Matsusaka, Taiji, Ohtsuka, Masato, Miura, Hiromi, Okuno, Yukiko, Asanuma, Katsuhiko, Nakagawa, Takahiko, Yanagita, Motoko, and Mori, Kiyoshi
- Subjects
- *
PROTEINURIA , *GLOMERULAR filtration rate , *NEPHRIN , *LABORATORY mice , *DOWNREGULATION - Abstract
Nephrin is a critical component of glomerular filtration barrier, which is important to maintain glomerular structure and avoid proteinuria. Downregulation of nephrin expression is commonly observed at early stage of glomerular disorders, suggesting that methods to increase nephrin expression in podocytes may have therapeutic utility. Here, we generated a knockin mouse line carrying single copy of 5.5 kb nephrin promoter controlling expression of enhanced green fluorescent protein (EGFP) at Rosa26 genomic locus (Nephrin-EGFP mouse). In these mice, EGFP was specifically expressed in podocytes. Next, we isolated and cultivated glomeruli from these mice, and developed a protocol to automatically quantitate EGFP expression in cultured glomeruli. EGFP signal was markedly reduced after 5 days of culture but reduction was inhibited by vitamin D treatment. We confirmed that vitamin D increased mRNA and protein expression of endogenous nephrin in cultivated glomeruli. Thus, we generated a mouse line converting nephrin promoter activity into fluorescence, which can be used to screen compounds having activity to enhance nephrin gene expression. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
82. Time-dependent dysregulation of autophagy: Implications in aging and mitochondrial homeostasis in the kidney proximal tubule.
- Author
-
Yamamoto, Takeshi, Takabatake, Yoshitsugu, Kimura, Tomonori, Takahashi, Atsushi, Namba, Tomoko, Matsuda, Jun, Minami, Satoshi, Kaimori, Jun-ya, Matsui, Isao, Kitamura, Harumi, Matsusaka, Taiji, Niimura, Fumio, Yanagita, Motoko, Isaka, Yoshitaka, and Rakugi, Hiromi
- Published
- 2016
- Full Text
- View/download PDF
83. ENOS deficiency causes podocyte injury with mitochondrial abnormality.
- Author
-
Ueda, Shuko, Ozawa, Shota, Mori, Kiyoshi, Asanuma, Katsuhiko, Yanagita, Motoko, Uchida, Shunya, and Nakagawa, Takahiko
- Subjects
- *
NITRIC-oxide synthases , *MITOCHONDRIAL DNA abnormalities , *GENETIC mutation , *LABORATORY mice , *KIDNEY cortex , *EPITHELIAL cells , *OXIDATIVE stress - Abstract
The contribution of endothelial nitric oxide synthase (eNOS) to podocyte integrity remains unclear. This study therefore examined podocytes and mitochondrial abnormalities in eNOS deficient mice. Absence of eNOS caused glomerular hypertrophy, along with occasional glomerular sclerosis and mesangiolysis. While many glomeruli did not have such advanced lesions, ultrastructural analysis showed cellular hypertrophy, vacuolization, lysosomal enlargement, and microvillus formation in podocytes of eNOS knockout (KO) mice. Increased oxidative stress was associated with mitochondrial abnormalities, including an increase in number, coupled with a reduction in size, of mitochondria in podocytes of eNOS-KO mice. While the levels of expression of several mitochondrial proteins were not altered, the d -17 mutation in mitochondrial DNA was significantly associated with the eNOS deficiency. Renal ATP level in the renal cortex and mitochondrial respiration in the primary podocytes were significantly lower in eNOS-KO mice, suggesting that renal mitochondria may be functionally impaired. Podocytes cultured with endothelial conditioned medium lacking NO consistently showed a greater degree of mitochondrial fragmentation and an increase in mitochondrial oxidative stress, with these mitochondrial alterations rescued by an NO donor. In conclusion, eNOS may be necessary to maintain podocyte integrity, especially mitochondrial function. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
84. Molecular Markers of Tubulointerstitial Fibrosis and Tubular Cell Damage in Patients with Chronic Kidney Disease.
- Author
-
Nakagawa, Shunsaku, Nishihara, Kumiko, Miyata, Hitomi, Shinke, Haruka, Tomita, Eri, Kajiwara, Moto, Matsubara, Takeshi, Iehara, Noriyuki, Igarashi, Yoshinobu, Yamada, Hiroshi, Fukatsu, Atsushi, Yanagita, Motoko, Matsubara, Kazuo, and Masuda, Satohiro
- Subjects
- *
CHRONIC kidney failure , *FIBROSIS , *GLOMERULAR filtration rate , *KIDNEY tubules , *NEPHRONS , *HISTOPATHOLOGY , *WOUNDS & injuries , *PATIENTS - Abstract
In chronic kidney disease (CKD), progressive nephron loss causes glomerular sclerosis, as well as tubulointerstitial fibrosis and progressive tubular injury. In this study, we aimed to identify molecular changes that reflected the histopathological progression of renal tubulointerstitial fibrosis and tubular cell damage. A discovery set of renal biopsies were obtained from 48 patients with histopathologically confirmed CKD, and gene expression profiles were determined by microarray analysis. The results indicated that hepatitis A virus cellular receptor 1 (also known as Kidney Injury Molecule-1, KIM-1), lipocalin 2 (also known as neutrophil gelatinase-associated lipocalin, NGAL), SRY-box 9, WAP four-disulfide core domain 2, and NK6 homeobox 2 were differentially expressed in CKD. Their expression levels correlated with the extent of tubulointerstitial fibrosis and tubular cell injury, determined by histopathological examination. The expression of these 5 genes was also increased as kidney damage progressed in a rodent unilateral ureteral obstruction model of CKD. We calculated a molecular score using the microarray gene expression profiles of the biopsy specimens. The composite area under the receiver operating characteristics curve plotted using this molecular score showed a high accuracy for diagnosing tubulointerstitial fibrosis and tubular cell damage. The robust sensitivity of this score was confirmed in a validation set of 5 individuals with CKD. These findings identified novel molecular markers with the potential to contribute to the detection of tubular cell damage and tubulointerstitial fibrosis in the kidney. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
85. Low Serum Neutrophil Gelatinase-associated Lipocalin Level as a Marker of Malnutrition in Maintenance Hemodialysis Patients.
- Author
-
Imamaki, Hirotaka, Ishii, Akira, Yokoi, Hideki, Kasahara, Masato, Kuwabara, Takashige, Mori, Keita P., Kato, Yukiko, Kuwahara, Takashi, Satoh, Masugi, Nakatani, Kimihiko, Saito, Yoshihiko, Tomosugi, Naohisa, Sugawara, Akira, Nakao, Kazuwa, Mukoyama, Masashi, Yanagita, Motoko, and Mori, Kiyoshi
- Subjects
- *
MALNUTRITION , *LEUCOCYTE elastase , *HEMODIALYSIS patients , *SERUM , *LIPOCALIN-2 , *GENETIC markers , *PATIENTS - Abstract
Background: Neutrophil gelatinase-associated lipocalin (NGAL or LCN2) is an iron-transporting factor which possesses various activities such as amelioration of kidney injury and host defense against pathogens. Its circulating concentrations are elevated in acute and chronic kidney diseases and show a positive correlation with poor renal outcome and mortality, but its clinical significance in maintenance hemodialysis (HD) patients remains elusive. Methods: Serum NGAL levels were determined by enzyme-linked immunosorbent assay in out-patient, Japanese HD subjects. Their correlation to laboratory findings and morbidity (as development of severe infection or serum albumin reduction) was investigated using linear regression analysis and χ2 test. Results: Pre-dialysis serum NGAL levels in HD patients were elevated by 13-fold compared to healthy subjects (n=8, P<0.001). In a cross-sectional study of 139 cases, serum NGAL concentrations were determined independently by % creatinine generation rate (an indicator of muscle mass, standardized coefficient β=0.40, P<0.001), peripheral blood neutrophil count (β=0.38, P<0.001) and anion gap (which likely reflects dietary protein intake, β=0.16, P<0.05). Iron administration to anemic HD patients caused marked elevation of peripheral blood hemoglobin, serum ferritin and iron-regulatory hormone hepcidin-25 levels, but NGAL levels were not affected. In a prospective study of 87 cases, increase in serum albumin levels a year later was positively associated to baseline NGAL levels by univariate analysis (r=0.36, P<0.01). Furthermore, within a year, patients with the lowest NGAL tertile showed significantly increased risk for marked decline in serum albumin levels (≥0.4 g/dl; odds ratio 5.5, 95% confidence interval 1.5–20.3, P<0.05) and tendency of increased occurrence of severe infection requiring admission (odds ratio 3.1, not significant) compared to the middle and highest tertiles. Conclusion: Low serum NGAL levels appear to be associated with current malnutrition and also its progressive worsening in maintenance HD patients. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
86. Fatty acid binding protein 3 as a potential mediator for diabetic nephropathy in eNOS deficient mouse.
- Author
-
Ozawa, Shota, Ueda, Shuko, Li, Ying, Mori, Kiyoshi, Asanuma, Katsuhiko, Yanagita, Motoko, and Nakagawa, Takahiko
- Subjects
- *
FATTY acids , *CARRIER proteins , *DIABETIC nephropathies , *NITROUS oxide , *LABORATORY mice , *GLOMERULAR filtration rate - Abstract
In human diabetic nephropathy, glomerular injury was found to comprise lipid droplets, suggesting that abnormal lipid metabolism might take place in the development of diabetic glomerular injury. However, its precise mechanism remains unclear. Fatty acid binding protein (FABP) is currently considered as a key molecule for lipid metabolism. Since diabetic eNOS knockout (KO) mouse is considered to be a good model for human diabetic nephropathy, we here investigated whether FABP could mediate glomerular injury in this model. We found that glomerular injuries were associated with inflammatory processes, such as macrophage infiltration and MCP-1 induction. Microarray assay with isolated glomeruli revealed that among 10 isoforms in FABP family, FABP3 mRNA was most highly expressed in diabetic eNOSKO mice compared to non-diabetic eNOSKO mice. FABP3 protein was found to be located in the mesangial cells. Overexpression of FABP3 resulted in a greater response to palmitate, a satulated FA, to induce MCP-1 in the rat mesangial cells. In turn, the heart, a major organ for FABP3 protein in normal condition, failed to alter its expression level under diabetic condition in either wild type or eNOSKO mice. In conclusion, FABP3 is induced in the mesangial cells and likely a mediator to induce MCP-1 in the diabetic nephropathy. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
87. Urinary Neutrophil Gelatinase-Associated Lipocalin: A Useful Biomarker for Tacrolimus-Induced Acute Kidney Injury in Liver Transplant Patients.
- Author
-
Tsuchimoto, Ayami, Shinke, Haruka, Uesugi, Miwa, Kikuchi, Mio, Hashimoto, Emina, Sato, Tomoko, Ogura, Yasuhiro, Hata, Koichiro, Fujimoto, Yasuhiro, Kaido, Toshimi, Kishimoto, Junji, Yanagita, Motoko, Matsubara, Kazuo, Uemoto, Shinji, and Masuda, Satohiro
- Subjects
- *
LIPOCALIN-2 , *BIOMARKERS , *ACUTE kidney failure , *LIVER transplantation , *IMMUNOSUPPRESSIVE agents , *TACROLIMUS , *MONOCYTE chemotactic factor , *PATIENTS - Abstract
Tacrolimus is widely used as an immunosuppressant in liver transplantation, and tacrolimus-induced acute kidney injury (AKI) is a serious complication of liver transplantation. For early detection of AKI, various urinary biomarkers such as monocyte chemotactic protein-1, liver-type fatty acid-binding protein, interleukin-18, osteopontin, cystatin C, clusterin and neutrophil gelatinase-associated lipocalin (NGAL) have been identified. Here, we attempt to identify urinary biomarkers for the early detection of tacrolimus-induced AKI in liver transplant patients. Urine samples were collected from 31 patients after living-donor liver transplantation (LDLT). Twenty recipients developed tacrolimus-induced AKI. After the initiation of tacrolimus therapy, urine samples were collected on postoperative days 7, 14, and 21. In patients who experienced AKI during postoperative day 21, additional spot urine samples were collected on postoperative days 28, 35, 42, 49, and 58. The 8 healthy volunteers, whose renal and liver functions were normal, were asked to collect their blood and spot urine samples. The urinary levels of NGAL, monocyte chemotactic protein-1 and liver-type fatty acid-binding protein were significantly higher in patients with AKI than in those without, while those of interleukin-18, osteopontin, cystatin C and clusterin did not differ between the 2 groups. The area under the receiver operating characteristics curve of urinary NGAL was 0.876 (95% confidence interval, 0.800–0.951; P<0.0001), which was better than those of the other six urinary biomarkers. In addition, the urinary levels of NGAL at postoperative day 1 (p = 0.0446) and day 7 (p = 0.0006) can be a good predictive marker for tacrolimus-induced AKI within next 6 days, respectively. In conclusion, urinary NGAL is a sensitive biomarker for tacrolimus-induced AKI, and may help predict renal event caused by tacrolimus therapy in liver transplant patients. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
88. Correction to: Validation of the diagnostic criteria for IgG4‑related kidney disease (IgG4‑RKD) 2011, and proposal of a new 2020 version.
- Author
-
Saeki, Takako, Kawano, Mitsuhiro, Nagasawa, Tasuku, Ubara, Yoshifumi, Taniguchi, Yoshinori, Yanagita, Motoko, Nishi, Shinichi, Nagata, Michio, Hisano, Satoshi, Yamaguchi, Yutaka, Nomura, Hideki, Saito, Takao, and Nakashima, Hitoshi
- Subjects
- *
KIDNEY diseases - Abstract
A correction to this paper has been published: https://doi.org/10.1007/s10157-021-02040-9 [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
89. The Authors Reply:.
- Author
-
Matsubara, Takeshi, Ogawa, Osamu, and Yanagita, Motoko
- Subjects
- *
BODY mass index , *PATHOLOGICAL physiology - Abstract
A response from the author of the article "Physical finding of nutcracker phenomenon" is presented.
- Published
- 2013
- Full Text
- View/download PDF
90. Twisted Gastrulation, a BMP Antagonist, Exacerbates Podocyte Injury.
- Author
-
Yamada, Sachiko, Nakamura, Jin, Asada, Misako, Takase, Masayuki, Matsusaka, Taiji, Iguchi, Taku, Yamada, Ryo, Tanaka, Mari, Higashi, Atsuko Y., Okuda, Tomohiko, Asada, Nariaki, Fukatsu, Atsushi, Kawachi, Hiroshi, Graf, Daniel, Muso, Eri, Kita, Toru, Kimura, Takeshi, Pastan, Ira, Economides, Aris N., and Yanagita, Motoko
- Subjects
- *
GASTRULATION , *BONE morphogenetic proteins , *EPITHELIAL cells , *GLOMERULOSCLEROSIS , *CELLULAR signal transduction , *CELL culture , *CELL proliferation - Abstract
Podocyte injury is the first step in the progression of glomerulosclerosis. Previous studies have demonstrated the beneficial effect of bone morphogenetic protein 7 (Bmp7) in podocyte injury and the existence of native Bmp signaling in podocytes. Local activity of Bmp7 is controlled by cell-type specific Bmp antagonists, which inhibit the binding of Bmp7 to its receptors. Here we show that the product of Twisted gastrulation (Twsg1), a Bmp antagonist, is the central negative regulator of Bmp function in podocytes and that Twsg1 null mice are resistant to podocyte injury. Twsg1 was the most abundant Bmp antagonist in murine cultured podocytes. The administration of Bmp induced podocyte differentiation through Smad signaling, whereas the simultaneous administration of Twsg1 antagonized the effect. The administration of Bmp also inhibited podocyte proliferation, whereas simultaneous administration of Twsg1 antagonized the effect. Twsg1 was expressed in the glomerular parietal cells (PECs) and distal nephron of the healthy kidney, and additionally in damaged glomerular cells in a murine model of podocyte injury. Twsg1 null mice exhibited milder hypoalbuminemia and hyperlipidemia, and milder histological changes while maintaining the expression of podocyte markers during podocyte injury model. Taken together, our results show that Twsg1 plays a critical role in the modulation of protective action of Bmp7 on podocytes, and that inhibition of Twsg1 is a promising means of development of novel treatment for podocyte injury. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
91. Adrenomedullin-RAMP2 System Suppresses ER Stress-Induced Tubule Cell Death and Is Involved in Kidney Protection.
- Author
-
Uetake, Ryuichi, Sakurai, Takayuki, Kamiyoshi, Akiko, Ichikawa-Shindo, Yuka, Kawate, Hisaka, Iesato, Yasuhiro, Yoshizawa, Takahiro, Koyama, Teruhide, Yang, Lei, Toriyama, Yuichi, Yamauchi, Akihiro, Igarashi, Kyoko, Tanaka, Megumu, Kuwabara, Takashige, Mori, Kiyoshi, Yanagita, Motoko, Mukoyama, Masashi, and Shindo, Takayuki
- Subjects
- *
ADRENOMEDULLIN , *CELL death , *BIOACTIVE compounds , *CALCITONIN gene-related peptide , *CALCITONIN receptors , *PHENOTYPES , *LABORATORY mice , *CELLULAR signal transduction , *THERAPEUTICS - Abstract
Various bioactive peptides have been implicated in the homeostasis of organs and tissues. Adrenomedullin (AM) is a peptide with various bioactivities. AM-receptor, calcitonin-receptor-like receptor (CLR) associates with one of the subtypes of the accessory proteins, RAMPs. Among the RAMP subisoforms, only RAMP2 knockout mice (−/−) reproduce the phenotype of embryonic lethality of AM−/−, illustrating the importance of the AM-RAMP2-signaling system. Although AM and RAMP2 are abundantly expressed in kidney, their function there remains largely unknown. We used genetically modified mice to assess the pathophysiological functions of the AM-RAMP2 system. RAMP2+/− mice and their wild-type littermates were used in a streptozotocin (STZ)-induced renal injury model. The effect of STZ on glomeruli did not differ between the 2 types of mice. On the other hand, damage to the proximal urinary tubules was greater in RAMP2+/−. Tubular injury in RAMP2+/− was resistant to correction of blood glucose by insulin administration. We examined the effect of STZ on human renal proximal tubule epithelial cells (RPTECs), which express glucose transporter 2 (GLUT2), the glucose transporter that specifically takes up STZ. STZ activated the endoplasmic reticulum (ER) stress sensor protein kinase RNA-like endoplasmic reticulum kinase (PERK). AM suppressed PERK activation, its downstream signaling, and CCAAT/enhancer-binding homologous protein (CHOP)-induced cell death. We confirmed that the tubular damage was caused by ER stress-induced cell death using tunicamycin (TUN), which directly evokes ER stress. In RAMP2+/− kidneys, TUN caused severe injury with enhanced ER stress. In wild-type mice, TUN-induced tubular damage was reversed by AM administration. On the other hand, in RAMP2+/−, the rescue effect of exogenous AM was lost. These results indicate that the AM-RAMP2 system suppresses ER stress-induced tubule cell death, thereby exerting a protective effect on kidney. The AM-RAMP2 system thus has the potential to serve as a therapeutic target in kidney disease. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
92. Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention.
- Author
-
Kitai, Yuichiro, Ozasa, Neiko, Morimoto, Takeshi, Bao, Bingyuan, Furukawa, Yutaka, Nakagawa, Yoshihisa, Kadota, Kazushige, Yanagita, Motoko, Shizuta, Satoshi, and Kimura, Takeshi
- Subjects
- *
ANEMIA , *KIDNEY diseases , *ANGIOPLASTY , *HEALTH outcome assessment , *PROGNOSTIC tests , *HEMOGLOBINS , *MYOCARDIAL infarction , *PATIENTS - Abstract
Abstract: Background: Little is known about the prognostic implications of anemia in patients undergoing elective percutaneous coronary intervention (PCI), especially when they have coexisting chronic kidney disease (CKD). Methods: We identified 7299 patients who underwent elective PCI from the CREDO-Kyoto registry cohort-2. The primary outcome was 3-year major adverse cardiac events (MACE); composite of all cause death, heart failure hospitalization, and myocardial infarction. Results: In total, 1466 patients (20.0%) had mild anemia (hemoglobin=11.0–11.9g/dL for women and 11.0–12.9g/dL for men), and 740 patients (10.1%) had moderate-to-severe anemia (hemoglobin<11.0g/dL both for women and for men). Compared to the no-anemia group, cumulative incidence of MACE was significantly higher in the mild and moderate-to-severe anemia groups (7.9%, 20.1%, and 34.2%, respectively). The adjusted hazard ratios of mild and moderate-to-severe anemia versus no-anemia for MACE were 1.77 (95% confidence interval: 1.47–2.15) and 2.53 (95% confidence interval: 2.03–3.14), respectively. In a subgroup analysis, significantly higher risk for MACE was consistently observed with mild and moderate-to-severe anemia both in patients with and without CKD. The risk for MACE showed an accretive increment with exacerbation in either the renal function or anemia (interaction p<0.001). Conclusions: Even mild anemia was associated with significantly worse 3-year clinical outcomes in patients who underwent elective PCI. Coexisting CKD additively increased the risk for MACE in these patients. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
93. Bmp7 Maintains Undifferentiated Kidney Progenitor Population and Determines Nephron Numbers at Birth.
- Author
-
Tomita, Mayumi, Asada, Misako, Asada, Nariaki, Nakamura, Jin, Oguchi, Akiko, Higashi, Atsuko Y., Endo, Shuichiro, Robertson, Elizabeth, Kimura, Takeshi, Kita, Toru, Economides, Aris N., Kreidberg, Jordan, and Yanagita, Motoko
- Subjects
- *
BONE morphogenetic proteins , *PROGENITOR cells , *CELL differentiation , *NEPHRONS , *HYPERTENSION risk factors , *KIDNEY diseases , *EMBRYOLOGY , *GERM cells - Abstract
The number of nephrons, the functional units of the kidney, varies among individuals. A low nephron number at birth is associated with a risk of hypertension and the progression of renal insufficiency. The molecular mechanisms determining nephron number during embryogenesis have not yet been clarified. Germline knockout of bone morphogenetic protein 7 (Bmp7) results in massive apoptosis of the kidney progenitor cells and defects in early stages of nephrogenesis. This phenotype has precluded analysis of Bmp7 function in the later stage of nephrogenesis. In this study, utilization of conditional null allele of Bmp7 in combination with systemic inducible Cre deleter mice enabled us to analyze Bmp7 function at desired time points during kidney development, and to discover the novel function of Bmp7 to inhibit the precocious differentiation of the progenitor cells to nephron. Systemic knockout of Bmp7 in vivo after the initiation of kidney development results in the precocious differentiation of the kidney progenitor cells to nephron, in addition to the prominent apoptosis of progenitor cells. We also confirmed that in vitro knockout of Bmp7 in kidney explant culture results in the accelerated differentiation of progenitor population. Finally we utilized colony-forming assays and demonstrated that Bmp7 inhibits epithelialization and differentiation of the kidney progenitor cells. These results indicate that the function of Bmp7 to inhibit the precocious differentiation of the progenitor cells together with its anti-apoptotic effect on progenitor cells coordinately maintains renal progenitor pool in undifferentiated status, and determines the nephron number at birth. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
94. Physical finding of nutcracker phenomenon.
- Author
-
Matsubara, Takeshi, Ogawa, Osamu, and Yanagita, Motoko
- Subjects
- *
CASE studies - Abstract
The article presents a case study of a 16-year-old adolescent boy who was referred to the nephrology department due to severe macrohematuria and anemia.
- Published
- 2013
- Full Text
- View/download PDF
95. Dclk1 distinguishes between tumor and normal stem cells in the intestine.
- Author
-
Nakanishi, Yuki, Seno, Hiroshi, Fukuoka, Ayumi, Ueo, Taro, Yamaga, Yuichi, Maruno, Takahisa, Nakanishi, Naoko, Kanda, Keitaro, Komekado, Hideyuki, Kawada, Mayumi, Isomura, Akihiro, Kawada, Kenji, Sakai, Yoshiharu, Yanagita, Motoko, Kageyama, Ryoichiro, Kawaguchi, Yoshiya, Taketo, Makoto M, Yonehara, Shin, and Chiba, Tsutomu
- Subjects
- *
CANCER stem cells , *BIOMARKERS , *COLON cancer treatment , *TARGETED drug delivery , *REGRESSION analysis , *POLYPS , *KINASES , *INTESTINAL tumors - Abstract
There is great interest in tumor stem cells (TSCs) as potential therapeutic targets; however, cancer therapies targeting TSCs are limited. A drawback is that TSC markers are often shared by normal stem cells (NSCs); thus, therapies that target these markers may cause severe injury to normal tissues. To identify a potential TSC-specific marker, we focused on doublecortin-like kinase 1 (Dclk1). Dclk1 was reported as a candidate NSC marker in the gut, but recent reports have implicated it as a marker of differentiated cells (for example, Tuft cells). Using lineage-tracing experiments, we show here that Dclk1 does not mark NSCs in the intestine but instead marks TSCs that continuously produce tumor progeny in the polyps of ApcMin/+ mice. Specific ablation of Dclk1-positive TSCs resulted in a marked regression of polyps without apparent damage to the normal intestine. Our data suggest the potential for developing a therapy for colorectal cancer based on targeting Dclk1-positive TSCs. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
96. Reduced BMP Signaling Results in Hindlimb Fusion with Lethal Pelvic/Urogenital Organ Aplasia: A New Mouse Model of Sirenomelia.
- Author
-
Suzuki, Kentaro, Adachi, Yasuha, Numata, Tomokazu, Nakada, Shoko, Yanagita, Motoko, Nakagata, Naomi, Evans, Sylvia M., Graf, Daniel, Economides, Aris, Haraguchi, Ryuma, Moon, Anne M., Yamada, Gen, and Bellusci, Saverio
- Subjects
- *
HUMAN abnormalities , *SYNDROMES , *BONE morphogenetic proteins , *HINDLIMB , *PHENOTYPES , *SIRENOMELIA ,GENITOURINARY organ abnormalities - Abstract
Sirenomelia, also known as mermaid syndrome, is a developmental malformation of the caudal body characterized by leg fusion and associated anomalies of pelvic/urogenital organs including bladder, kidney, rectum and external genitalia. Most affected infants are stillborn, and the few born alive rarely survive beyond the neonatal period. Despite the many clinical studies of sirenomelia in humans, little is known about the pathogenic developmental mechanisms that cause the complex array of phenotypes observed. Here, we provide new evidences that reduced BMP (Bone Morphogenetic Protein) signaling disrupts caudal body formation in mice and phenocopies sirenomelia. Bmp4 is strongly expressed in the developing caudal body structures including the peri-cloacal region and hindlimb field. In order to address the function of Bmp4 in caudal body formation, we utilized a conditional Bmp4 mouse allele (Bmp4flox/flox) and the Isl1 (Islet1)-Cre mouse line. Isl1-Cre is expressed in the peri-cloacal region and the developing hindimb field. Isl1Cre;Bmp4flox/flox conditional mutant mice displayed sirenomelia phenotypes including hindlimb fusion and pelvic/urogenital organ dysgenesis. Genetic lineage analyses indicate that Isl1-expressing cells contribute to both the aPCM (anterior Peri-Cloacal Mesenchyme) and the hindlimb bud. We show Bmp4 is essential for the aPCM formation independently with Shh signaling. Furthermore, we show Bmp4 is a major BMP ligand for caudal body formation as shown by compound genetic analyses of Bmp4 and Bmp7. Taken together, this study reveals coordinated development of caudal body structures including pelvic/urogenital organs and hindlimb orchestrated by BMP signaling in Isl1-expressing cells. Our study offers new insights into the pathogenesis of sirenomelia. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
97. Comparison of the psychosocial quality of life in hemodialysis patients between the elderly and non-elderly using a visual analogue scale: The importance of appetite and depressive mood.
- Author
-
Kanamori, Hiroshi, Nagai, Kojiro, Matsubara, Takeshi, Mima, Akira, Yanagita, Motoko, Iehara, Noriyuki, Takechi, Hajime, Fujimaki, Keiichi, Usami, Kazumasa, Fukatsu, Atsushi, Kita, Toru, Matsubayashi, Kozo, and Arai, Hidenori
- Subjects
- *
HEMODIALYSIS , *QUALITY of life , *MENTAL health , *AGE distribution , *APPETITE , *BLOOD testing , *CHI-squared test , *COMPARATIVE studies , *MENTAL depression , *LONGITUDINAL method , *MEDICAL cooperation , *MULTIVARIATE analysis , *QUESTIONNAIRES , *REGRESSION analysis , *RESEARCH , *SURVIVAL analysis (Biometry) , *U-statistics , *VISUAL analog scale , *RELATIVE medical risk , *PROPORTIONAL hazards models , *DATA analysis software , *PSYCHOLOGY - Abstract
Aim: The number of hemodialysis (HD) patients is increasing along with their mean age in Japan. The assessment of their psychosocial status and quality of life (QOL) is therefore becoming more and more important along with laboratory data or comorbidities. Methods: We examined the psychosocial status of 211 HD patients (72 elderly and 139 non-elderly) and compared the difference between elderly and non-elderly patients using a visual analogue scale (VAS). We then examined how QOL affected mortality rate in 3-year prospective follow up. We assessed 10 items of QOL: health condition, appetite, sleep, mood, memory, family relationships, friendship, economical status, life satisfaction in daily life, and happiness with qualified self-evaluating questionnaires along with laboratory data and comorbidities. Furthermore, we investigated the correlation between the scores of mood and geriatric depression scale (GDS)-15. Results: There was no difference in VAS scores between elderly and non-elderly patients. Lower VAS scores for appetite and mood correlated with higher mortality in HD patients, especially in the non-elderly. VAS scores for mood correlated with GDS-15 in HD patients. Conclusions: More attention should be paid to appetite and the diagnosis and therapy of depressive mood to improve the prognosis of HD patients, especially for the non-elderly. Geriatr Gerontol Int 2012; 12: 65-71. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
98. Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice.
- Author
-
Asada, Nariaki, Takase, Masayuki, Nakamura, Jin, Oguchi, Akiko, Asada, Misako, Suzuki, Norio, Yamamura, Ken-ichi, Nagoshi, Narihito, Shibata, Shinsuke, Rao, Tata Nageswara, Fukatsu, Atsushi, Minegishi, Naoko, Kita, Toru, Kimura, Takeshi, Okano, Hideyuki, Yamamoto, Masayuki, Yanagita, Motoko, and Fehling, Hans Joerg
- Subjects
- *
KIDNEY diseases , *FIBROBLASTS , *FIBROSIS , *RENAL anemia , *ERYTHROPOIETIN , *CELL differentiation , *BIOLOGICAL models , *RESEARCH , *KIDNEYS , *COMBINATION drug therapy , *ANIMAL experimentation , *RESEARCH methodology , *ORGANIC compounds , *DOPA , *MEDICAL cooperation , *EVALUATION research , *COMPARATIVE studies , *ANEMIA , *MICE - Abstract
In chronic kidney disease, fibroblast dysfunction causes renal fibrosis and renal anemia. Renal fibrosis is mediated by the accumulation of myofibroblasts, whereas renal anemia is mediated by the reduced production of fibroblast-derived erythropoietin, a hormone that stimulates erythropoiesis. Despite their importance in chronic kidney disease, the origin and regulatory mechanism of fibroblasts remain unclear. Here, we have demonstrated that the majority of erythropoietin-producing fibroblasts in the healthy kidney originate from myelin protein zero-Cre (P0-Cre) lineage-labeled extrarenal cells, which enter the embryonic kidney at E13.5. In the diseased kidney, P0-Cre lineage-labeled fibroblasts, but not fibroblasts derived from injured tubular epithelial cells through epithelial-mesenchymal transition, transdifferentiated into myofibroblasts and predominantly contributed to fibrosis, with concomitant loss of erythropoietin production. We further demonstrated that attenuated erythropoietin production in transdifferentiated myofibroblasts was restored by the administration of neuroprotective agents, such as dexamethasone and neurotrophins. Moreover, the in vivo administration of tamoxifen, a selective estrogen receptor modulator, restored attenuated erythropoietin production as well as fibrosis in a mouse model of kidney fibrosis. These findings reveal the pathophysiological roles of P0-Cre lineage-labeled fibroblasts in the kidney and clarify the link between renal fibrosis and renal anemia. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
99. Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.
- Author
-
Tanaka, Mari, Asada, Misako, Higashi, Atsuko Y., Nakamura, Jin, Oguchi, Akiko, Tomita, Mayumi, Yamada, Sachiko, Asada, Nariaki, Takase, Masayuki, Okuda, Tomohiko, Kawachi, Hiroshi, Economides, Aris N., Robertson, Elizabeth, Takahashi, Satoru, Sakurai, Takeshi, Goldschmeding, Roel, Muso, Eri, Fukatsu, Atsushi, Kita, Toru, and Yanagita, Motoko
- Subjects
- *
BASAL lamina , *KIDNEYS , *ALPORT syndrome , *BONE morphogenetic proteins , *LABORATORY mice , *ACUTE kidney failure , *KIDNEY tubules , *KIDNEY glomerulus - Abstract
The glomerular basement membrane (GBM) is a key component of the filtering unit in the kidney. Mutations involving any of the collagen IV genes (COL4A3, COL4A4, and COL4A5) affect GBM assembly and cause Alport syndrome, a progressive hereditary kidney disease with no definitive therapy. Previously, we have demonstrated that the bone morphogenetic protein (BMP) antagonist uterine sensitization-associated gene-1 (USAG-1) negatively regulates the renoprotective action of BMP-7 in a mouse model of tubular injury during acute renal failure. Here, we investigated the role of USAG-1 in renal function in Col4a3-/- mice, which model Alport syndrome. Ablation of Usag1 in Col4a3-/- mice led to substantial attenuation of disease progression, normalization of GBM ultrastructure, preservation of renal function, and extension of life span. Immunohistochemical analysis revealed that USAG-1 and BMP-7 colocalized in the macula densa in the distal tubules, lying in direct contact with glomerular mesangial cells. Furthermore, in cultured mesangial cells, BMP-7 attenuated and USAG-1 enhanced the expression of MMP-12, a protease that may contribute to GBM degradation. These data suggest that the pathogenetic role of USAG-1 in Col4a3-/- mice might involve crosstalk between kidney tubules and the glomerulus and that inhibition of USAG-1 may be a promising therapeutic approach for the treatment of Alport syndrome. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
100. Case of soluble fms-like tyrosine kinase 1 apheresis in severe pre-eclampsia developed at 15 weeks' gestation.
- Author
-
Nakakita, Baku, Mogami, Haruta, Kondoh, Eiji, Tsukamoto, Tatsuo, Yanagita, Motoko, and Konishi, Ikuo
- Subjects
- *
BLOOD pressure , *DEXTRAN , *GESTATIONAL age , *HEMAPHERESIS , *PLACENTA , *PREECLAMPSIA , *PROTEIN-tyrosine kinases - Abstract
Soluble fms-like tyrosine kinase-1 (sFlt1), a circulating vascular endothelial growth factor receptor 1 antagonist, is associated with the pathogenesis of pre-eclampsia. Extracorporeal removal of sFlt1 (sFlt1 apheresis) is emerging as a treatment for pre-eclampsia. We performed sFlt1 apheresis for a patient with very early onset pre-eclampsia, beginning at 15 weeks' gestation. She underwent sFlt1 apheresis 13 times from 19 to 23 weeks' gestation. The series of treatments lowered circulating sFlt1, stabilized blood pressure, reduced urinary protein, and preserved renal function, which contributed to a successful prolongation of pregnancy for 4 weeks and a live birth at 23+3 weeks' gestation. Further studies are necessary for clinical application of sFlt1 apheresis as sFlt1 might have a protective function for the placenta and fetus in pre-eclampsia. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.